Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001125282-04-005621
Filing Date
2004-11-10
Accepted
2004-11-10 17:27:04
Documents
5
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A b401843_10ka.txt 10-K/A 465815
2 EXHIBIT 12.1 b401843ex12_1.txt EX-12.1 3037
3 EXHIBIT 23.0 b401843ex23_0.txt EX-23.0 1299
4 EXHIBIT 31.1 b401843ex31_1.txt EX-31.1 4043
5 EXHIBIT 32.1 b401843ex32_1.txt EX-32.1 1806
  Complete submission text file 0001125282-04-005621.txt   478216
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-12957 | Film No.: 041134166
SIC: 2836 Biological Products, (No Diagnostic Substances)